Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension

NCT00034307 is registered in ClinicalTrials.gov with ICOS-Texas Biotechnology as lead sponsor.

NCT NCT00034307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
Lead sponsor
ICOS-Texas Biotechnology
Phase
Phase 2/3
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
180
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension